Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ICCC

Immucell Corp

11.20

Jul 15 • 11:45AM ET -0.52 (-4.46%)

Healthcare Biotechnology USA Micro NASD

Peers: ANIX ANVS COYA CYPH EXOZ FBIO INO MCRB XBIT ATYR

| Held by: VTI VXF IWC DFAT DCOR DFMC DFSU DFAC DXUV

Scroll to Statements

Index	-
Market Cap	101.30M
Enterprise Value	107.27M
Income	-0.55M
Sales	29.93M
Book/sh	3.22
Cash/sh	0.75
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	73
IPO	May 05, 1987

P/E	-
Forward P/E	-
PEG	-
P/S	3.38
P/B	3.48
P/C	14.88
P/FCF	29.97
EV/EBITDA	21.07
EV/Sales	3.58
Quick Ratio	2.60
Current Ratio	4.82
Debt/Eq	0.44
LT Debt/Eq	0.38
Option/Short	No / Yes

EPS (ttm)	-0.06
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	29.01% 4.06%
Sales past 3/5Y	14.19% 12.50%
EPS Y/Y TTM	4.90%
Sales Y/Y TTM	9.64%
EPS Q/Q	33.21%
Sales Q/Q	28.39%
Earnings	May 14 AMC
EPS/Sales Surpr.	- -

Insider Own	37.77%
Insider Trans	0.23%
Inst Own	15.03%
Inst Trans	1.29%
ROA	-1.22%
ROE	-1.88%
ROIC	-1.36%
Gross Margin	42.59%
Oper. Margin	8.35%
Profit Margin	-1.82%
SMA20	8.73%
SMA50	14.35%
SMA200	55.29%
Trades

Shs Outstand	9.05M
Shs Float	5.63M
Short Float	0.33%
Short Ratio	0.62
Short Interest	0.02M
52W High	12.10 -7.46%
52W Low	4.52 147.72%
Volatility	6.01% 4.84%
ATR (14)	0.58
RSI (14)	59.91
Beta	0.56
Rel Volume	3.29
Avg Volume	30.12K
Volume	38,038

Perf Week	5.33%
Perf Month	15.67%
Perf Quarter	44.85%
Perf Half Y	67.87%
Perf YTD	82.07%
Perf Year	78.87%
Perf 3Y	119.98%
Perf 5Y	24.41%
Perf 10Y	63.51%
Recom	-
Target Price	-
Prev Close	11.72
Price	11.20
Change	-4.46%

Jul-09-26 04:05PM	ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results (GlobeNewswire) +7.76%
May-15-26 07:01PM	ImmuCell Corp (ICCC) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth (GuruFocus.com) +7.99% +11.10%
May-14-26 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 (GlobeNewswire)
May-07-26 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 (GlobeNewswire)
Apr-13-26 04:38PM	ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors (GlobeNewswire) +8.72%
04:05PM	Loading…
Apr-08-26 04:05PM	ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results (GlobeNewswire) +12.70%
Mar-18-26 04:05PM	ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board (GlobeNewswire)
Mar-06-26 08:02PM	ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
12:43PM	ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve (Zacks)
Mar-05-26 09:07PM	ImmuCell Q4 Earnings Call Highlights (MarketBeat)
08:30AM	ImmuCell Corporation Q4 2025 Earnings Call Summary (Moby)
Mar-04-26 04:05PM	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 (GlobeNewswire)
Feb-18-26 08:37AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 (GlobeNewswire)
Jan-15-26 11:24AM	Niche Focus & Regulation Shape the Future of Healthcare Firms (Zacks)
Jan-09-26 11:02AM	ImmuCell Q4 Earnings Call Highlights (MarketBeat)
04:05PM	Loading…
Jan-08-26 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 (GlobeNewswire) +5.29%
Jan-07-26 08:10AM	ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus (GlobeNewswire)
Dec-26-25 01:53AM	The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio (Zacks) +5.52%
Dec-24-25 01:10PM	Top Stock Reports for AbbVie, Coca-Cola & Chevron (Zacks)
01:05PM	ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain (GlobeNewswire)
Dec-04-25 11:14AM	ImmuCell's Two-Product Edge in Cattle Health Fuels Growth (Zacks)
Nov-24-25 08:02PM	ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-20-25 07:42AM	ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength (Zacks)
Nov-13-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025 (GlobeNewswire) -10.74%
Nov-06-25 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 (GlobeNewswire)
Nov-04-25 04:05PM	ImmuCell Announces Onboarding of New CEO and Related Management Changes (GlobeNewswire) +5.00%
Oct-09-25 09:37AM	The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne (Zacks)
Oct-08-25 05:07PM	Top Stock Reports for SAP, Novartis & Philip Morris (Zacks)
Oct-07-25 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025 (GlobeNewswire)
Sep-29-25 04:05PM	ImmuCell Announces Selection of its Next President and CEO (GlobeNewswire)
12:57PM	Loading…
Sep-09-25 12:57PM	FONAR's Stock Advances 5% in Three Months: Key Trends Ahead (Zacks) -6.03%
Aug-21-25 10:47AM	ImmuCell Swings to Q2 Profit on Strong Sales, Shares Still Slide (Zacks)
Aug-18-25 09:00AM	ImmuCell Corp (ICCC) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Margin Expansion ... (GuruFocus.com)
Aug-14-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025 (GlobeNewswire) -9.18%
Aug-12-25 04:05PM	ImmuCell Announces Bank Debt Refinancing (GlobeNewswire)
Aug-07-25 08:00AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025 (GlobeNewswire)
Jul-22-25 11:55AM	ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside (Zacks)
Jul-18-25 09:43AM	The Zacks Analyst Blog Highlights Alphabet, Oracle, Shell, Fossil and ImmuCell (Zacks)
Jul-17-25 11:46PM	Top Research Reports for Alphabet, Oracle & Shell (Zacks)
Jul-09-25 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025 (GlobeNewswire)
Jun-25-25 08:00AM	ImmuCell Embarks on CEO Succession Planning Process (GlobeNewswire) -10.78%
Jun-05-25 06:30AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-19-25 11:36AM	ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains (Zacks)
May-16-25 05:00PM	ImmuCell Corp (ICCC) Q1 2025 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... (GuruFocus.com)
May-14-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025 (GlobeNewswire) +7.94%
May-12-25 08:42AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 (GlobeNewswire)
Apr-17-25 04:23AM	The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell (Zacks)
Apr-16-25 05:02PM	Top Stock Reports for Netflix, SAP & Shell (Zacks)
Apr-08-25 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 (GlobeNewswire) -10.59%
Apr-07-25 09:00AM	ImmuCell Hires Chief Financial Officer (GlobeNewswire)
Apr-02-25 04:05PM	ImmuCell Announces Initiation of Investigational Product Use of Re-Tain® (GlobeNewswire) +8.40%
Feb-27-25 04:00PM	ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ... (GuruFocus.com)
Feb-25-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 (GlobeNewswire) +7.45%
Feb-20-25 08:19AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 (GlobeNewswire)
Jan-16-25 04:05PM	ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses (GlobeNewswire) +5.16%
Jan-09-25 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024 (GlobeNewswire)
Nov-13-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 (GlobeNewswire)
Nov-07-24 08:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 (GlobeNewswire)
Oct-08-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 (GlobeNewswire)
Aug-13-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 (GlobeNewswire)
Aug-07-24 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 (GlobeNewswire)
Jul-09-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 (GlobeNewswire)
Jun-05-24 04:05PM	ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain (GlobeNewswire)
Jun-04-24 04:05PM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-14-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 (GlobeNewswire) -10.89%
May-08-24 01:00PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 (GlobeNewswire)
Apr-09-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 (GlobeNewswire)
Feb-29-24 08:25AM	ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 (GlobeNewswire)
Feb-16-24 09:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 (GlobeNewswire)
Jan-08-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023 (GlobeNewswire) +5.01%
Nov-15-23 02:04PM	ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.28%
Nov-13-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023 (GlobeNewswire)
Nov-07-23 12:15PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023 (GlobeNewswire)
Oct-05-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023 (GlobeNewswire)
Aug-29-23 08:00AM	ImmuCell Announces Submission of CMC Technical Section to the FDA (GlobeNewswire)
Aug-11-23 10:16PM	Q2 2023 ImmuCell Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-10-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023 (GlobeNewswire)
Aug-07-23 12:00PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023 (GlobeNewswire)
Jul-11-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023 (GlobeNewswire)
Jun-28-23 04:05PM	ImmuCell Announces Change in Timing of Anticipated FDA Submission (GlobeNewswire) -10.35%
Jun-21-23 04:05PM	ImmuCell Appoints Bryan K. Gathagan to Board of Directors (GlobeNewswire)
Jun-15-23 04:05PM	ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility (GlobeNewswire) +8.53%
May-16-23 09:00AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-15-23 07:36AM	There's No Escaping ImmuCell Corporation's (NASDAQ:ICCC) Muted Revenues (Simply Wall St.) +7.11%
May-12-23 09:46PM	Q1 2023 ImmuCell Corp Earnings Call (Thomson Reuters StreetEvents) -6.46%
May-11-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
May-04-23 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
Apr-05-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023 (GlobeNewswire)
Feb-23-23 05:26AM	ImmuCell Full Year 2022 Earnings: US$0.32 loss per share (vs US$0.01 loss in FY 2021) (Simply Wall St.)
Feb-21-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022 (GlobeNewswire) -6.84%
Feb-15-23 11:55AM	ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022 (GlobeNewswire)
Jan-09-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022 (GlobeNewswire) +8.55%
Dec-23-22 10:24PM	ImmuCell Corporation (NASDAQ:ICCC) Q3 2022 Earnings Call Transcript (Insider Monkey)
Nov-21-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022 (GlobeNewswire) -11.27%
Nov-10-22 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022 (GlobeNewswire)
Oct-24-22 06:20AM	Investors in ImmuCell (NASDAQ:ICCC) have made a decent return of 48% over the past three years (Simply Wall St.)
Oct-05-22 06:30AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022 (GlobeNewswire)
Sep-14-22 05:00PM	ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference (GlobeNewswire)
Aug-12-22 09:00AM	Edited Transcript of ICCC.OQ earnings conference call or presentation 12-Aug-22 1:00pm GMT (Thomson Reuters StreetEvents) -6.86%

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. It operates through the following segments: Scours and Mastitis. The Scours segment consists of the First Defense product line. The Mastitis segment includes the CMT product line consisting of reagents and equipment used for rapid cow-side testing to identify mastitic quarters by detecting elevated somatic cell counts. The company was founded in 1982 and is headquartered in Portland, ME.

PresidentMr. Paul F. Olivier Te Boekhorst

CFOMr. Timothy C. Fiori

Senior Vice President of Sales & MarketingMs. Bobbi Jo Brockmann

Director of Finance & Administration and ControllerMs. Elizabeth S. Toothaker

Senior Director of QualityMr. A. Gustavo Scaffa

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
te Boekhorst Paul Francis Oliv	President and CEO	Jun 18 '26	Buy	9.49	8,000	75,960	17,785	Jun 22 08:33 AM
BRIGHAM MICHAEL F	Director	Mar 20 '26	Option Exercise	5.84	25,000	146,000	229,752	Mar 24 07:57 PM
te Boekhorst Paul Francis Oliv	President and CEO	Dec 03 '25	Buy	5.02	6,077	30,536	9,785	Dec 03 04:14 PM
te Boekhorst Paul Francis Oliv	President and CEO	Dec 02 '25	Buy	4.87	3,708	18,053	3,708	Dec 03 04:14 PM
Tomsche David Scott	Director	Nov 25 '25	Buy	4.76	1,633	7,781	4,740	Nov 28 08:12 AM
Tomsche David Scott	Director	Nov 25 '25	Buy	4.76	1,633	7,773	52,720	Nov 28 08:12 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICCC

Immucell Corp

Upgrade your Finviz experience